RAB5A and Alzheimer disease: In this study, we first examined total Rab5a and Rab5a‐GTP expression levels to determine the pathological changes in 5 × FAD mice and further explore the possible molecular mechanism by which Rab5a affects BFCNs function in the early stage of AD.